FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

EPI Health minolira Recall

minolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample…

EPI Health, LLC · Charleston, SC

Risk level
Class III
Reported by FDA
Oct 2, 2019
Recall ID
D-0120-2020
Check your lot numberHow we source this data

Summary

EPI Health recalled minolira starting Aug 26, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0120-2020 on Oct 2, 2019. Reason: Failed Dissolution Specifications:. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications:

Product description

minolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets, Rx Only, Mfg by: Dr. Reddy's Laboratories Limited, FTO-SEZ, Process Unit-01 Devunipalavalasa Village Srikakulam (District) Andhra Pradesh, INDIA. Manufactured for: EPI Health, LLC 134 Columbus St. Charleston, SC 29403 USA. NDC 71403-102-05.

Lot numbers, UPCs & expiration codes

Lot# T900093, Exp 11/2020

Where it was sold

Firm recalling only from EPI Field Representatives.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0120-2020
Classification
Class III
Status
Terminated
Recall initiated
Aug 26, 2019
FDA report date
Oct 2, 2019
Quantity
1,626 5-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
EPI Health, LLC

Original FDA data

Every field from FDA enforcement report D-0120-2020, exactly as published.

Show all FDA fields
City
Charleston
State
SC
Status
Terminated
Country
United States
Event ID
83809
Address
134 Columbus St
Code information
Lot# T900093, Exp 11/2020
Postal code
29403-4809
Report date
Oct 2, 2019
Product type
Drugs
Recall number
D-0120-2020
Classification
Class III
Recalling firm
EPI Health, LLC
Product quantity
1,626 5-count bottles
Termination date
Aug 18, 2021
Reason for recall
Failed Dissolution Specifications:
Voluntary / mandated
Voluntary: Firm initiated
Product description
minolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets, Rx Only, Mfg by: Dr. Reddy's Laboratories Limited, FTO-SEZ, Process Unit-01 Devunipalavalasa Village Srikakulam (District) Andhra Pradesh, INDIA. Manufactured for: EPI Health, LLC 134 Columbus St. Charleston, SC 29403 USA. NDC 71403-102-05.
Distribution pattern
Firm recalling only from EPI Field Representatives.
Recall initiation date
Aug 26, 2019
Initial firm notification
E-Mail
Center classification date
Oct 2, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0120-2020, published Oct 2, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls